Delivery Order SPE2DB20D1100-SPE2DB24FD5U1

Award Date 8/30/24
Potential Completion Date 9/23/24
Potential Value $110K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $22,081.68 Firm Fixed Price Delivery Order is for the supply of 4,565,404,280 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 9, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop...
This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $11,040.84 delivery order is for DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of September 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this contract without any set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $198,735.12 Firm Fixed Price Delivery Order is for the supply of 4,565,227,359 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024 and was awarded on July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $33,122.52, is a delivery order for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 20, 2024 and utilizes a Firm Fixed Price pricing type. The award is not designated as a set-aside contract. AmerisourceBergen, one of the largest...
This federal contract award, valued at $23,920.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $33,122.52 Delivery Order is for the provision of 4,564,490,081 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price, with a completion date of May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $124,028.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP0U3) for the supply of DARZALEX FASPRO, a specialty medication, with an ultimate completion date of July 22, 2022. The contract is a firm fixed-price arrangement, and no set-aside designation was used. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $22,081.68 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has a completion date of September 25, 2024. AmerisourceBergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,112.20 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract is a firm fixed-price Delivery Order with a completion date of January 10, 2025. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5U1
    Delivery Order

This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 23, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of critical medical commodities, including prescription drugs, vaccines, and medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This contract award is not designated as a set-aside.

Generated 11/29/24, 9:10 AM